...
首页> 外文期刊>Platelets >Two novel variants of uncertain significance in GP9 associated with Bernard-Soulier syndrome: Are they true mutations?
【24h】

Two novel variants of uncertain significance in GP9 associated with Bernard-Soulier syndrome: Are they true mutations?

机译:与伯纳尔 - 灵魂综合征相关的GP9中不确定意义的两种新变种:它们是否真正突变?

获取原文
获取原文并翻译 | 示例
           

摘要

Bernard-Soulier syndrome (BSS) is an autosomal recessive major thrombocytopathy, the symptoms of which are mainly marked by mucocutaneous bleeding. This rare disease, initially described in the 1970s, is the result of an abnormal formation of the glycoprotein complex Ib-IX-V (GP Ib-IX-V), a platelet receptor of von Willebrand factor. A large number of mutations, sometimes involving the GP9 gene, have been described as possibly responsible for the disease. We report here the case of a BSS patient who presented with persistent thrombocytopenia (31x10(9)/L) and decreased surface expression of GPIb-IX-V on large platelets with anisocytosis. Thorough molecular analyses disclosed two previously unreported GP9 variants, respectively c.230TA (p.Leu77Gln) and c.255CA (p.Asn85Lys). Both are likely to modify the conformation of GP-IX interactions with other glycoproteins of the Ib-IX-V complex and thus proper expression of this complex on the membrane of platelets.
机译:Bernard-Sourier综合征(BSS)是一种常染色体隐性主要血小板病变,其症状主要由粘皮肤出血标记。 这种罕见的疾病最初在20世纪70年代描述,是糖蛋白复合物IB-IX-V(GP IB-IX-V)的异常形成,von Willebrand因子的血小板受体。 已经描述了大量突变,有时涉及GP9基因,可能对该疾病负责。 在此报告此处的BSS患者患有持续血小板减少症(31x10(9)/ L)的病例(31x10(9)/ L),并在具有异胞菌作用的大血小板上降低GPIB-IX-V的表面表达。 彻底的分子分析公开了两个先前未报告的GP9变体,分别为C.230T> A(P.LEU77GLN)和C.255C> a(p.asn85s)。 两者都可能改变与IB-IX-V复合物的其他糖蛋白的GP-IX相互作用的构象,因此在血小板膜上适当地表达该络合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号